Home/Filings/4/0000950170-25-065310
4//SEC Filing

Hensley Mark Earl 4

Accession 0000950170-25-065310

CIK 0000818033other

Filed

May 6, 8:00 PM ET

Accepted

May 7, 12:20 PM ET

Size

5.5 KB

Accession

0000950170-25-065310

Insider Transaction Report

Form 4
Period: 2025-05-06
Hensley Mark Earl
Chief Operating Officer
Transactions
  • Award

    Restricted Stock Units

    2025-05-06+500,000500,000 total
    Exercise: $0.00Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installmens thereafter.

Documents

1 file

Issuer

HERON THERAPEUTICS, INC. /DE/

CIK 0000818033

Entity typeother

Related Parties

1
  • filerCIK 0002065816

Filing Metadata

Form type
4
Filed
May 6, 8:00 PM ET
Accepted
May 7, 12:20 PM ET
Size
5.5 KB